Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 10/1998

01-10-1998

Case Report: Recovery from Life-Threatening, Corticosteroid-Unresponsive, Chemotherapy-Related Reactivation of Hepatitis B Associated with Lamivudine Therapy

Authors: Frank Ter Borg, Suzanne Smorenburg, Robert A. De Man, Ron C. Rietbroek, Rob A. F. M. Chamuleau, E. Anthony Jones

Published in: Digestive Diseases and Sciences | Issue 10/1998

Login to get access
Metadata
Title
Case Report: Recovery from Life-Threatening, Corticosteroid-Unresponsive, Chemotherapy-Related Reactivation of Hepatitis B Associated with Lamivudine Therapy
Authors
Frank Ter Borg
Suzanne Smorenburg
Robert A. De Man
Ron C. Rietbroek
Rob A. F. M. Chamuleau
E. Anthony Jones
Publication date
01-10-1998
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 10/1998
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1026622807373

Other articles of this Issue 10/1998

Digestive Diseases and Sciences 10/1998 Go to the issue

OriginalPaper

Effect of S -Adenosyl-L-Methionine and Dilinoleoylphosphatidylcholine on Liver Lipid Composition and Ethanol Hepatotoxicity in Isolated Perfused Rat Liver

OriginalPaper

Interleukin-8 Enhances Tetragastrin-Stimulated Acid Secretion In Vivo

BookReview

Book Reviews

OriginalPaper

Frequency and Significance of Anti-gliadin and Anti-endomysial Antibodies in Autoimmune Hepatitis

OriginalPaper

Oral Administration of Rapamycin and Cyclosporine Differentially Alter Intestinal Function in Rabbits

OriginalPaper

Indomethacin and Pancreatic Enzymes Synergistically Damage Intestine of Rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits